The prevalence of sickle cell disease is changing how Nigerians date, marry and plan their lives. And as genetic testing becomes more common, prospective parents across the world will face similar questions. By Krithika Varagur
Ian Sample speaks to Guardian science correspondent Hannah Devlin about the latest developments and debates about gene editing to emerge from a summit at the Francis Crick Institute in London. The summit heard from the first person with sickle cell disease to be treated with a technique known as CRISPR. He also hears from Prof Claire Booth about ensuring these cutting edge treatments are made available to everyone who needs them
Attitudes to race need to change if sickle cell patients are to get the treatment they need